IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,557,270 | +1.8% | 253,446 | 0.0% | 0.22% | +61.9% |
| Q3 2022 | $2,512,000 | +1.0% | 253,446 | 0.0% | 0.14% | +2.2% |
| Q2 2022 | $2,486,000 | +0.1% | 253,446 | 0.0% | 0.14% | +8.8% |
| Q1 2022 | $2,483,000 | +1.0% | 253,446 | 0.0% | 0.12% | +2.5% |
| Q4 2021 | $2,458,000 | +0.1% | 253,446 | 0.0% | 0.12% | -12.2% |
| Q3 2021 | $2,455,000 | – | 253,446 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |